Workflow
Beat Market Volatility With 4 Low-Beta Stocks: PGR, PSO, TXO & JAZZ
PGRProgressive(PGR) ZACKS·2025-03-06 14:05

Market Overview - The U.S. stock market is expected to remain volatile due to uncertainty surrounding trade policies, economic concerns, and shifts in investor sentiment, particularly influenced by President Trump's tariffs on major trading partners [1] - Retaliatory measures from trading partners have heightened market anxiety, despite temporary rebounds from hopes for tariff concessions [1] - Key economic indicators such as jobless claims, payroll reports, and corporate earnings are likely to further influence market movements [1] Investment Strategy - Creating a curated portfolio of low-beta stocks is recommended as a strategy to safeguard against market fluctuations [2] - Low-beta stocks such as The Progressive Corporation (PGR), Pearson plc (PSO), TXO Partners LP (TXO), and Jazz Pharmaceuticals plc (JAZZ) are highlighted as potential investment opportunities [2] Company Highlights The Progressive Corporation (PGR) - In 2024, PGR reported a 21% year-over-year increase in net premiums written, totaling 74.4billion,withactivepoliciesgrowingbyover5million[7]Thecompanyachievedan88.8combinedratio,outperformingits96target,drivenbystrongclaimsmanagementandoperationalefficiencies[7]PGRscompetitiveadvantagesinpricingandcustomerservicepositionitwellforcontinuedgrowthintheinsurancesector[7]Pearsonplc(PSO)Pearsonexperienceda374.4 billion, with active policies growing by over 5 million [7] - The company achieved an 88.8 combined ratio, outperforming its 96 target, driven by strong claims management and operational efficiencies [7] - PGR's competitive advantages in pricing and customer service position it well for continued growth in the insurance sector [7] Pearson plc (PSO) - Pearson experienced a 3% sales growth in 2024, with profits rising by 10% and an EBIT margin of 16.9% [9] - Strategic partnerships with AWS and Microsoft are enhancing Pearson's AI capabilities and expanding enterprise learning opportunities [9] - The company's leadership in assessments and innovative digital offerings support its long-term growth outlook [9] Jazz Pharmaceuticals plc (JAZZ) - Jazz Pharmaceuticals reported annual revenues exceeding 4 billion in 2024, with fourth-quarter revenues reaching a record $1.09 billion [10] - The company's diversified portfolio in sleep, epilepsy, and oncology continues to drive growth, with key products showing strong performance [10] - Robust cash flow and a strong pipeline position JAZZ for continued growth and value creation [10] TXO Partners LP (TXO) - TXO Partners has a strong presence in the oil-rich Permian Basin, benefiting from exploration and production activities [11] - The Mancos Shale project, covering 58,500 contiguous acres, holds nearly 3 trillion cubic feet of natural gas potential, which could significantly increase reserves [11] - Phase I of the project targets a 3,520-acre block estimated to hold 200-300 billion cubic feet of natural gas, potentially doubling existing reserves [11]